Profile
Michael A.
Yamin served as the Director & Vice President at Angion Biomedica Corp.
from 2013 to 2020.
Prior to that, he obtained a doctorate degree from The Rockefeller University.
Former positions of Michael A. Yamin
| Companies | Position | End |
|---|---|---|
| ANGN BIOM | Director/Board Member | 04/06/2020 |
Training of Michael A. Yamin
| The Rockefeller University | Doctorate Degree |
Experiences
Positions held
Connections
11
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Stock Market
- Insiders
- Michael A. Yamin
